Agricultural Research Service, USDA.
Notice of availability and intent.
Notice is hereby given that the Federally owned invention disclosed in U.S. Patent Application No. 10/184,005, “Use of Recombinant Bovine CD14 in the Treatment and Prevention of Coliform Mastitis in Dairy Cows”, filed on June 27, 2002, is available for licensing and that the U.S. Department of Agriculture, Agricultural Research Service, intends to grant to Monsanto Company of St. Louis, Missouri, an exclusive license to this invention.
Comments must be received within ninety (90) calendar days of the date of publication of this Notice in the Federal Register.
Send comments to: USDA, ARS, Office of Technology Transfer, 5601 Sunnyside Avenue, Room 4-1174, Beltsville, Maryland 20705-5131.Start Further Info
FOR FURTHER INFORMATION CONTACT:
June Blalock of the Office of Technology Transfer at the Beltsville address given above; telephone: 301-504-5989.End Further Info End Preamble Start Supplemental Information
The Federal Government's patent rights to this invention are assigned to the United States of America, as represented by the Secretary of Agriculture. It is in the public interest to so license this invention as Monsanto Company of St. Louis, Missouri, has submitted a complete and sufficient application for a license. The prospective exclusive license will be royalty-bearing and will comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7. The prospective exclusive license may be granted unless, within ninety (90) days from the date of this published Notice, the Agricultural Research Service receives written evidence and argument which establishes that the grant of the license would not be consistent with the requirements of 35 U.S.C. 209 and 37 CFR 404.7.Start Signature
Richard J. Brenner,
[FR Doc. 04-28060 Filed 12-22-04; 8:45 am]
BILLING CODE 3410-03-P